In this week's video, Dr. Brian Durie discusses Selinexor, a novel, orally administered drug that is currently ongoing clinical trials.
Selinexor is a promising new type of drug that can make a difference for myeloma patients.
Visit our website at: http://www.myeloma.org
Find us online:
IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyeloma)
Dr. Durie on twitter: @BrianDurieMD (http://twitter.com/brianduriemd)